Confirmation of reactive hepatitis E virus IgM antibody screening test results for the diagnosis of acute or recent (<6 months) hepatitis E infection For information see Hepatitis E: Testing Algorithm for Diagnosis and Management. Applies only to results expressed in units of measure originally reported by the performing laboratory.

Definitive diagnosis of hepatitis E infection

Positive results confirm the presence of acute or recent (in the preceding 6 months) hepatitis E infection. Negative results indicate absence of acute or recent hepatitis E infection.

The Hepatitis E Virus (HEV) IgM Antibody test, also known as Anti-HEV IgM, is used to detect IgM antibodies produced in response to acute Hepatitis E virus infection. Here's how to interpret the test results: Positive Result: A positive Anti-HEV IgM result indicates the presence of IgM antibodies against Hepatitis E virus in the blood. Interpretation: A positive result suggests recent or acute Hepatitis E virus infection. IgM antibodies typically appear early during the acute phase of infection (within 2-3 weeks of onset of symptoms) and may persist for a few months before declining. Acute Hepatitis E infection is often symptomatic and may present with symptoms such as jaundice, fatigue, abdominal pain, nausea, vomiting, and fever. Confirmation of acute Hepatitis E infection may require additional testing, such as detection of HEV RNA by PCR. Negative Result: A negative Anti-HEV IgM result suggests the absence of detectable IgM antibodies against Hepatitis E virus in the blood. Interpretation: A negative result may indicate the absence of recent Hepatitis E virus infection. However, false-negative results are possible, particularly if the test is performed too early during the acute phase of infection when IgM antibodies have not yet developed. Repeat testing may be necessary if clinical suspicion for Hepatitis E infection remains high despite a negative result. Clinical Correlation: Interpretation of Anti-HEV IgM test results should be done in conjunction with the patient's clinical history, symptoms, and other laboratory findings. Additional diagnostic tests, such as detection of HEV RNA by PCR or Anti-HEV IgG antibody testing, may be necessary to confirm the diagnosis and differentiate between acute and past Hepatitis E infection. Limitations: The sensitivity and specificity of Anti-HEV IgM tests may vary, and false-positive or false-negative results are possible. Cross-reactivity with antibodies against other viruses (e.g., Hepatitis A virus) may occur, leading to false-positive results. False-negative results may occur if the test is performed outside the window period when IgM antibodies are detectable. Public Health Implications: Hepatitis E is a public health concern, particularly in regions with poor sanitation and hygiene practices. Prompt diagnosis and appropriate management of acute Hepatitis E infection are important to prevent complications and reduce transmission. Interpretation of Anti-HEV IgM test results should be performed by healthcare providers experienced in the diagnosis and management of viral hepatitis. It's essential to consider the patient's clinical context, symptoms, and other relevant factors when interpreting these results and determining the appropriate diagnosis and management plan. Confirmation of diagnosis may require additional testing and clinical evaluation.

Blood